AQT90 FLEX NTproBNP2 Test Kit Matrix Comparison and Sample Stability Verification Study

Launched by RADIOMETER MEDICAL APS · Mar 25, 2025

Keywords

ClinConnect Summary

This clinical trial is focused on testing a new diagnostic tool called the NTproBNP2 Test Kit, which is used to measure certain heart-related markers in patients. Researchers want to understand how different types of samples (like blood) affect the test results and how long these samples remain stable for accurate testing. This study is important because it will help improve the reliability of heart condition diagnoses using this test.

To participate in the trial, you need to be at least 18 years old, able to understand the study details, and willing to sign a consent form. Additionally, you should have certain expected levels of the NT-proBNP marker in your blood. However, if you are pregnant, breastfeeding, or have already taken part in this study before, you would not be eligible. If you join, you can expect to provide samples for testing and help researchers gather valuable information that could lead to better heart health assessments in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Subjects must be able to understand given information and demonstrate willingness and ability to voluntarily give a signed, valid written informed consent to participate in the study.
• • Subjects must be 18 years of age or older.
• • Subjects with expected NT-proBNP concentrations within the measuring range of NTproBNP2 Test Kit.
• Exclusion Criteria:
• • Subjects known to be pregnant or breast-feeding.
• • Subjects previously enrolled in the study.
• • Subject, who has withdrawn consent.